Related Experiment Video
Updated: May 10, 2026
08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
[Research advance in von Willebrand factor]
Xue-Mei Li1, Miao Jiang, Yi-Ming Zhao
1Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Province, China. meijuan1989123@163.com
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|July 3, 2013
Summary
Von Willebrand factor (vWF) is crucial for blood clotting. Understanding vWF regulation aids in diagnosing and treating bleeding disorders and thrombosis.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Context:
- Von Willebrand factor (vWF) is a key glycoprotein in hemostasis.
- vWF is synthesized in endothelial cells and megakaryocytes.
- vWF's function is vital for primary and secondary hemostasis.
Purpose:
- To review the regulation of vWF activity.
- To explore the relationship between vWF and various diseases.
- To enhance understanding of vWF-related pathophysiology.
Summary:
- vWF is essential for blood clot formation.
- vWF deficiency causes von Willebrand disease (vWD).
- vWF overexpression is linked to thrombotic events.
Impact:
- Informs the pathophysiology of vWD, TTP, venous thrombosis, and stroke.
- Aids in developing diagnostic and therapeutic strategies for vWF-related disorders.
- Highlights the critical role of vWF in hemostasis and disease.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.